Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Novozymes A/S (OTC: NVZMY).

Full DD Report for NVZMY

You must become a subscriber to view this report.


Recent News from (OTC: NVZMY)

Novozymes A/S 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 24 2018 10:03
Novozymes A/S 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 13 2018 13:57
Treasure Hunting In The OTC Market
Background Even after the recent sell-off in US stocks, the market still looks expensive by many metrics, including the Warren Buffett Indicator now telling you not to bet on America... well, at least not to bet solely on America. Even currently overpriced, the US stocks account for just n...
Source: SeekingAlpha
Date: June, 22 2018 14:35
International Flavors & Fragrances: That Taste In Your Mouth - Bitter Or Sweet?
International Flavors & Fragrances ( IFF ) announced a $7.1b agreement to acquire Frutarom, a supplier of flavor of ingredients. In our view, Frutarom’s business is seen as an adjacency to IFF’s. Frutarom is neither a large supplier to IFF nor a key competitor. Its customer ...
Source: SeekingAlpha
Date: June, 18 2018 15:29
Value Hunting Overseas
Expensive US Market In January, I wrote this article , warning about a possible downturn in the US stock market in light of the then all-time-high Warren Buffett Indicator (i.e., the Market-Cap-to-GDP ratio of 149% vs. the historical average of 75%). No matter whether you like the theory of...
Source: SeekingAlpha
Date: May, 30 2018 11:55
Novozymes A/S 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 26 2018 15:10
A Quantitative Approach To Finding Wide-Moat Stocks
In one of the previous articles , we focused on the importance and characteristics of moats when it comes to stock investing: by keeping the competition away, companies with wide moats are able to consistently capture a great portion of their economic value, and hence, generate superior retur...
Source: SeekingAlpha
Date: April, 02 2018 09:46
Novozymes: An Opportunity For Conservative Investors
Golden times come back again For many years, Novozymes ([[NVZMF]], [[NVZMY]]) has been a guarantor for capital gains. Since 2000 the stock price has been rising to nearly 900%. Adding dividends with a long-term CAGR of 16%, we approach a 1000% yield. The reason for this is simple: Novozymes ...
Source: SeekingAlpha
Date: March, 23 2018 12:32
Novozymes (NVZMY) Investor Presentation - Slideshow
The following slide deck was published by Novozymes A/S ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 14 2018 15:21
Novozymes A/S ADR 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S ADR in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 08 2018 13:23

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-0746.2445.7546.5145.7334,079
2018-12-0645.342545.75345.8345.2473,855
2018-12-0547.7346.53547.7346.4153,609
2018-12-0447.7346.53547.7346.4153,609
2018-12-0346.9646.71547.0346.6028,726

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-073,16334,0769.2822Cover
2018-12-062,58271,7153.6004Cover
2018-12-042,26353,6094.2213Cover
2018-12-035,77728,72620.1107Cover
2018-11-3014,49137,35238.7958Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVZMY.


About Novozymes A/S (OTC: NVZMY)

Logo for Novozymes A/S (OTC: NVZMY)

Novozymes is the biotech based world leader in enzymes and microorganisms. With more than types of enzymes and microorganisms and not less than different products Novozymes has the largest product portfolio in the world. lt br / gt In more than different industries and countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange.

 

 

 

Current Management

  • Steen Riisgaard / President, CEO
  • Thomas Steenbech Bonhoff / Head of IR

Current Share Structure

  • Market Cap: $2,859,584,969 - 03/09/2018
  • Issue and Outstanding: 54,251,280 - 07/21/2011

 


Recent Filings from (OTC: NVZMY)

Post-effective amendment to a previously filed F-6
Filing Type: F-6 POSFiling Source: edgar
Filing Date: September, 29 2017

 

 


Daily Technical Chart for (OTC: NVZMY)

Daily Technical Chart for (OTC: NVZMY)


Stay tuned for daily updates and more on (OTC: NVZMY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: NVZMY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVZMY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NVZMY and does not buy, sell, or trade any shares of NVZMY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/